The 25th International
Annual Congress of the
World Muscle Society

WMS 2020 Virtual Congress Industry Symposia

We are delighted to introduce a dedicated day in the WMS 2020 Virtual Congress Programme for our WMS Industry Symposia.

WMS Industry Symposia 1 – Antisense oligonucleotides for the treatment of neuromuscular diseases, Biogen


WMS Industry Symposia 2 – Duchenne muscular dystrophy: The role of real-world evidence in transforming the therapeutic outlook, PTC Therapeutics


WMS Industry Symposia 3 – Identify, Treat & Follow: Role of Gene Therapy in Spinal Muscular Atrophy (SMA), AveXis


WMS Industry Symposia 4 – Insights on the Neuromuscular and Respiratory Impairments in Pompe Disease, Sanofi Genzyme


WMS Industry Symposia 5 – The New Era of Gene Transfer Therapies and Application to Duchenne Muscular Dystrophy and Limb Girdle Muscular Dystrophies, Sarepta Therapeutics


WMS Industry Symposia 6 – Beyond motor function improvements: what is meaningful for people living with SMA?, Roche


The schedule for the day is as follows:

Monday 28th September 2020

15:00-16:30 WMS Industry Symposia 1 and 2
(2 x 90 minute parallel sessions incorporating live Q&A)

17:00 – 18:30 WMS Industry Symposia 3 and 4
(2 x 90 minute parallel sessions incorporating live Q&A)

19:00 – 20:30 WMS Industry Symposia 5 and 6
(2 x 90 minute parallel sessions incorporating live Q&A)

Please note, all times stated in the programme are in British Summer Time (BST).

Congress Organiser:

Azura Events Ltd, Devon, UK
Office: +44 (0) 1803 732362 Mobile: +44 (0) 7584 176583
On behalf of WMS Congress Ltd. Registered Company Number 10385332
VAT Registration Number: GB 250494608
Copyright © WMS Congress Ltd

Azura Events
WMS 2019 Congress